{
  "id": "SCR-LIP-000630",
  "statement": "Lipedema is reported to involve systemic and adipose tissue inflammation.",
  "claim_type": "clinical_association",
  "context": {
    "population": "women with lipedema",
    "condition": "lipedema",
    "exposure": "lipedema diagnosis",
    "comparator": "BMI-matched obese controls",
    "outcome": "glycemic, lipid, inflammatory, and oxidative stress markers",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.3389/fendo.2022.1000094",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2022,
      "amato_authored": false,
      "note": "This cross-sectional study directly compares metabolic and inflammatory biomarkers in lipedema versus BMI-matched obese controls, providing nuanced evidence that partially supports (glycemic protection, higher adiponectin) but also contradi",
      "title": "Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters?",
      "authors": "Nankam et al.",
      "journal": "Frontiers in Endocrinology",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "The article directly reports lower HbA1c (5.55±0.62% vs 6.73±0.85%), higher adiponectin (4.69±1.99 vs 3.28±1.00 µg/mL), higher LDL-C (3.38±0.68 vs 2.38±0.66 mmol/L), elevated ALAT, greater oxidative stress markers (MDA, catalase, SOD), and ",
        "date": "2026-06-10"
      },
      "quote": "21 de 78 proteínas inflamatórias significativamente elevadas no lipedema vs controles (p_adj<0.05); nenhuma foi maior nos controles — perfil pró-inflamatório sistêmico forte",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "refines",
      "finding": "21 of 78 inflammatory proteins elevated in lipedema vs BMI-matched controls (none higher in controls); also lower HbA1c and higher adiponectin but higher LDL-cholesterol, liver enzymes and oxidative stress.",
      "from_claims": [
        "SCR-LIP-000108"
      ]
    },
    {
      "ref": "DOI:10.3390/ijms25031599",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2024,
      "amato_authored": false,
      "note": "Large observational study showing lipedema (peripheral fat) is associated with increasing inflammation, insulin resistance, and adverse lipid profile with stage, with CRP elevation persisting after adjustment for BMI — contradicting the not",
      "title": "Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History",
      "authors": "Patton et al.",
      "journal": "International Journal of Molecular Sciences",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "contradicting",
        "verdict": "verified",
        "reason": "All specific numbers in the statement (CRP 1.38→4.93 mg/L, HOMA-IR 1.75→2.92, 34% glucose alterations, HDL decrease, obesity 6.3%→91.8%) are directly present in the article abstract. The source contradicts the notion that lipedema/gynoid fa",
        "date": "2026-06-10"
      },
      "quote": "PCR aumenta com estágio: Estágio 1: 1,38±1,29 mg/L → Estágio 2: 1,94±1,69 mg/L → Estágio 3: 4,93±4,35 mg/L (p<0,001); diferença mantida após correção para idade e IMC",
      "extraction_confidence": "high",
      "stance_in_source_claim": "contradicting",
      "finding": "In 360 Italian women with lipedema, CRP rose from 1.38 to 4.93 mg/L across stages (p<0.001, persisting after age and BMI adjustment); HOMA-IR rose, 34% had glucose metabolism alterations, HDL fell.",
      "from_claims": [
        "SCR-LIP-000301"
      ]
    },
    {
      "title": "Adipose tissue remodeling in lipedema: adipocyte death and concurrent regeneration",
      "ref": "DOI:10.1111/j.1600-0560.2009.01256.x",
      "stance": "supporting",
      "study_design": "case_report",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2009,
      "amato_authored": false,
      "quote": "characterized by crown-like structures (necrotizing adipocytes surrounded by infiltrating CD68+ macrophages; a feature commonly seen in obese adipose tissue)",
      "extraction_confidence": "moderate",
      "note": "The article reports that lipedema fat exhibits obesity-like inflammatory and degenerative features (crown-like structures, macrophage recruitment, hypertrophy, hypoxia cycle), which argues against the notion that peripheral/gynoid fat is me",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "contradicting",
        "verdict": "verified",
        "reason": "The article directly reports crown-like structures with CD68+ macrophages, adipocyte hypertrophy >150 μm vs ~100 μm, and Ki67+CD34+ proliferating ASCs in lipedema tissue, and explicitly draws the parallel to obesity-like hypoxia/necrosis me",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "contradicting",
      "finding": "Case report of severe lipedema tissue: obesity-like crown-like structures with CD68+ macrophages, adipocyte hypertrophy (>150 μm) and adipose stem cell proliferation, suggesting a hypoxia-necrosis-regeneration cycle.",
      "from_claims": [
        "SCR-LIP-000575"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000108",
    "SCR-LIP-000301",
    "SCR-LIP-000575"
  ],
  "questions_consolidated": [
    "SQ-LIP-000010"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00242",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000010"
    }
  ],
  "statement_pt": "O lipedema é relatado como envolvendo inflamação sistêmica e do tecido adiposo.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000010",
      "role": "contradicting",
      "question": "Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000010.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000630.html"
}